Long COVID Trial, Recruiting (NCT05566483)

Long COVID Trial, Recruiting NCT05566483 Sponsor: University of Colorado, Denver Condition: Long COVID

Printed from Voxsanity (voxsanity.com.au) — NCT05566483 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Long Covid

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older, have been diagnosed with COVID-19, and have had ongoing symptoms consistent with Long COVID for more than 12 weeks after your diagnosis.

Who may not be able to join:

You had a heart or lung condition before getting COVID-19.
You have had heart damage linked to COVID-19, such as inflammation of the heart muscle (confirm with trial site).
You developed blood clots in your legs or lungs after having COVID-19.
You have difficulty exercising due to a condition unrelated to your heart, lungs, or nervous system — for example, joint problems like osteoarthritis or other muscle and bone conditions.
You need to use supplemental oxygen because of heart or lung complications that developed after having COVID-19.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 303-724-2085

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05566483

Sponsor: University of Colorado, Denver

Phase: Not Applicable

Status: Recruiting

Condition: Long COVID

Trial contact: 303-724-2085

More information: https://clinicaltrials.gov/study/NCT05566483

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older, have been diagnosed with COVID-19, and have had ongoing symptoms consistent with Long COVID for more than 12 weeks after your diagnosis.

Who may not be able to join:

You had a heart or lung condition before getting COVID-19.
You have had heart damage linked to COVID-19, such as inflammation of the heart muscle (confirm with trial site).
You developed blood clots in your legs or lungs after having COVID-19.
You have difficulty exercising due to a condition unrelated to your heart, lungs, or nervous system — for example, joint problems like osteoarthritis or other muscle and bone conditions.
You need to use supplemental oxygen because of heart or lung complications that developed after having COVID-19.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Colorado, Denver

Registry

ClinicalTrials.gov

Start date

1 March 2023

Est. completion

31 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Characterizing the impact of exercise training (cardiac rehabilitation) on functional capacity among patients with Long COVID; Characterizing the impact of exercise training (cardiac rehabilitation) on HRqOL among patients with Long COVID

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov